The renin–angiotensin system plays a central role in MetS, with enhanced activation of angiotensin II precursors, increased angiotensin II activity, and upregulated expression of angiotensin receptor 1 observed as a consequence of hyperglycemia and insulin resistance. This evidence concerns the gene REN and Insulin resistance.